US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

0.7959

-0.0652-7.57%

Volume:1.06M

Turnover:879.10K

Market Cap:46.54M

PE:-1.19

High:0.8662

Open:0.8500

Low:0.7907

Close:0.8611

52wk High:1.80

52wk Low:0.3067

Shares:58.48M

Float Shares:42.26M

Volume Ratio:0.65

T/O Rate:2.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6709

EPS(LYR):-0.8450

ROE:-376.23%

ROA:-69.37%

PB:10.22

PE(LYR):-0.94

Loading ...

Overview Company News Filings

Femasys Secures FDA Clearance for Next-Generation FemVue Controlled Device

Femasys Secures U.S. FDA Clearance for Next-Generation Femvue Diagnostic Device

THOMSON REUTERS

PharmaCyte sells Femasys stake, sees cash position rising to $20M

Femasys Initiated at Buy by Laidlaw & Co.

Femasys initiated with a Buy at Laidlaw

Femasys: Strategic Advancements and Financial Health Justify Buy Rating

Femasys Q3 sales rise, driven by FemBloc sales

Femasys Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $729.394K Miss $1.450M Estimate

Femasys Inc. reports nine-month sales of $1.48 million and net loss of $14.68 million

Femasys Inc. Q3 EPS USD -0.1

THOMSON REUTERS

Press Release: Femasys Announces Third Quarter Financial Results for 2025

Femasys advances global growth with second partner order for FemBloc in Europe

Femasys Secures $500,000 Order for FemBloc Launch in France and Benelux

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

Femasys Secures $12 Million Through Private Placement

Femasys Inc. Announces Private Placement of Convertible Notes and Warrants

Femasys Secures FDA IDE Approval to Advance Final FemBloc Trial Phase

Femasys Inc: Agreement to Issue $12 Mln Principal Amount of Senior Secured Convertible Notes, Warrants to Purchase Shares of Common Stock for $58 Mln

THOMSON REUTERS

Femasys Secures FDA Approval to Advance Final Fembloc® Trial Phase and $12 Million Financing, With Potential to Reach $58 Million

THOMSON REUTERS

Femasys: to Use $12 Mln Notes Proceeds to Refinance Existing Debt, Advance Commercialization of Co's' Fertility and Permanent Birth Control Portfolio

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FEMY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FEMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FEMY\",,,,,undefined,":{"symbol":"FEMY","market":"US","secType":"STK","nameCN":"Femasys Inc","latestPrice":0.7959,"timestamp":1766437200000,"preClose":0.8611,"halted":0,"volume":1058678,"delay":0,"floatShares":42260600,"shares":58479799,"eps":-0.67086,"marketStatus":"Pre-Mkt","change":-0.0652,"latestTime":"12-23 05:42:17 EST","open":0.85,"high":0.866249,"low":0.7907,"amount":879096.9175797399,"amplitude":0.087735,"askPrice":0.8901,"askSize":100,"bidPrice":0.75,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.67086,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":0.7959,"postHourTrading":{"tag":"盘后","latestPrice":0.805,"preClose":0.7959,"latestTime":"19:56 EST","volume":46177,"amount":37898.9901,"timestamp":1766451414889},"volumeRatio":0.6510949225454602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FEMY\",,,,,undefined,":{"symbol":"FEMY","floatShares":42260600,"roa":"-69.37%","roe":"-376.23%","lyrEps":-0.845019,"volumeRatio":0.6510949225454602,"shares":58479799,"dividePrice":0,"high":0.866249,"amplitude":0.087735,"preClose":0.8611,"low":0.7907,"week52Low":0.3067,"pbRate":"10.22","psRate":"22.58","week52High":1.8,"institutionHeld":0,"latestPrice":0.7959,"committee":-0.818182,"eps":-0.67086,"divideRate":0,"volume":1058678,"delay":0,"ttmEps":-0.67086,"open":0.85,"prevYearClose":1.1,"prevWeekClose":0.8611,"prevMonthClose":1.01,"prevQuarterClose":0.3524,"fiveDayClose":0.8673,"twentyDayClose":0.92,"sixtyDayClose":0.3598},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FEMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"FEMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-08","symbol":"FEMY","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2021-08-11","symbol":"FEMY","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1628654400000,"reportTimeType":"","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FEMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FEMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1763874000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FEMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FEMY","date":"2025-12-19","current":-1.186388,"percent":0.294224,"low":-23.366735,"twenty":-3.211789,"median":-1.625025,"eighty":-1.239552,"high":-0.39417,"avg":-3.163319,"sd":3.877711,"marketCap":46544174},"quantilePoints":[{"date":"2021-06-18","current":-21.569294,"twenty":-23.366735,"median":-23.366735,"eighty":-22.28827,"marketCap":141138612},{"date":"2021-06-25","current":-15.368122,"twenty":-22.647759,"median":-19.142748,"eighty":-17.819832,"marketCap":100561261},{"date":"2021-07-02","current":-13.247141,"twenty":-20.742471,"median":-17.776693,"eighty":-14.606007,"marketCap":86682630},{"date":"2021-07-09","current":-13.60663,"twenty":-19.358442,"median":-14.66712,"eighty":-13.671338,"marketCap":89034941},{"date":"2021-07-16","current":-13.462834,"twenty":-18.603516,"median":-14.613197,"eighty":-13.347798,"marketCap":88094016},{"date":"2021-07-23","current":-14.361555,"twenty":-17.862971,"median":-14.577248,"eighty":-13.347798,"marketCap":93974792},{"date":"2021-07-30","current":-13.121321,"twenty":-17.294979,"median":-14.352568,"eighty":-13.1357,"marketCap":85859322},{"date":"2021-08-06","current":-12.959551,"twenty":-15.350148,"median":-13.930169,"eighty":-13.121321,"marketCap":84800782},{"date":"2021-08-13","current":-13.546101,"twenty":-15.260276,"median":-13.827699,"eighty":-13.121321,"marketCap":83188026},{"date":"2021-08-20","current":-12.873599,"twenty":-15.084126,"median":-13.546101,"eighty":-13.013474,"marketCap":79058124},{"date":"2021-08-27","current":-12.960064,"twenty":-14.663525,"median":-13.480809,"eighty":-12.96579,"marketCap":79589111},{"date":"2021-09-03","current":-14.084102,"twenty":-15.084126,"median":-13.546101,"eighty":-12.993649,"marketCap":86491947},{"date":"2021-09-10","current":-14.449174,"twenty":-15.044818,"median":-13.815101,"eighty":-13.013474,"marketCap":88733894},{"date":"2021-09-17","current":-13.699815,"twenty":-14.66712,"median":-13.827699,"eighty":-13.013474,"marketCap":84132003},{"date":"2021-09-24","current":-14.583674,"twenty":-14.649146,"median":-13.815101,"eighty":-13.013474,"marketCap":89559874},{"date":"2021-10-01","current":-13.834315,"twenty":-14.649146,"median":-13.803284,"eighty":-13.013474,"marketCap":84957984},{"date":"2021-10-08","current":-13.584529,"twenty":-14.583674,"median":-13.680601,"eighty":-13.027314,"marketCap":83424020},{"date":"2021-10-15","current":-13.450029,"twenty":-14.577248,"median":-13.690208,"eighty":-13.031448,"marketCap":82598040},{"date":"2021-10-22","current":-13.373172,"twenty":-14.56446,"median":-13.680601,"eighty":-13.046528,"marketCap":82126051},{"date":"2021-10-29","current":-13.315529,"twenty":-14.449174,"median":-13.670994,"eighty":-13.121321,"marketCap":81772059},{"date":"2021-11-05","current":-13.930387,"twenty":-14.449174,"median":-13.619115,"eighty":-13.046528,"marketCap":85547970},{"date":"2021-11-12","current":-12.313482,"twenty":-14.449174,"median":-13.612872,"eighty":-13.027314,"marketCap":84132003},{"date":"2021-11-19","current":-8.652251,"twenty":-14.449174,"median":-13.546101,"eighty":-12.988885,"marketCap":59116597},{"date":"2021-11-26","current":-7.840562,"twenty":-14.422217,"median":-13.480809,"eighty":-12.955956,"marketCap":53570728},{"date":"2021-12-03","current":-7.840562,"twenty":-14.411692,"median":-13.466038,"eighty":-12.830175,"marketCap":53570728},{"date":"2021-12-10","current":-7.702403,"twenty":-14.371393,"median":-13.450029,"eighty":-12.737142,"marketCap":52626751},{"date":"2021-12-17","current":-7.115224,"twenty":-14.347176,"median":-13.440421,"eighty":-12.535942,"marketCap":48614846},{"date":"2021-12-23","current":-7.909642,"twenty":-14.257065,"median":-13.430814,"eighty":-11.819561,"marketCap":54042717},{"date":"2021-12-31","current":-6.735285,"twenty":-14.164802,"median":-13.373172,"eighty":-9.104723,"marketCap":46018908},{"date":"2022-01-07","current":-5.630007,"twenty":-14.130216,"median":-13.349153,"eighty":-8.420833,"marketCap":38467087},{"date":"2022-01-14","current":-5.457308,"twenty":-14.099473,"median":-13.315529,"eighty":-7.88201,"marketCap":37287115},{"date":"2022-01-21","current":-4.852859,"twenty":-14.037988,"median":-13.238671,"eighty":-7.771483,"marketCap":33157213},{"date":"2022-01-28","current":-5.060099,"twenty":-13.960547,"median":-13.157269,"eighty":-7.477893,"marketCap":34573179},{"date":"2022-02-04","current":-5.681817,"twenty":-13.941041,"median":-13.046528,"eighty":-7.115224,"marketCap":38821078},{"date":"2022-02-11","current":-5.008289,"twenty":-13.930387,"median":-13.029381,"eighty":-6.925254,"marketCap":34219188},{"date":"2022-02-18","current":-5.301878,"twenty":-13.9303,"median":-13.013474,"eighty":-6.431334,"marketCap":36225140},{"date":"2022-02-25","current":-5.198258,"twenty":-13.92637,"median":-12.988885,"eighty":-6.027216,"marketCap":35517157},{"date":"2022-03-04","current":-3.868471,"twenty":-13.896998,"median":-12.959808,"eighty":-5.681817,"marketCap":26431372},{"date":"2022-03-11","current":-3.609422,"twenty":-13.839101,"median":-12.873599,"eighty":-5.581651,"marketCap":24661414},{"date":"2022-03-18","current":-3.436722,"twenty":-13.834315,"median":-12.824843,"eighty":-5.464216,"marketCap":23481442},{"date":"2022-03-25","current":-3.47649,"twenty":-13.834315,"median":-12.796742,"eighty":-5.322602,"marketCap":26205246},{"date":"2022-04-01","current":-3.319892,"twenty":-13.830472,"median":-12.695867,"eighty":-5.205166,"marketCap":25024829},{"date":"2022-04-08","current":-3.097678,"twenty":-13.811258,"median":-12.537992,"eighty":-5.163718,"marketCap":23349818},{"date":"2022-04-14","current":-2.505579,"twenty":-13.795887,"median":-12.313482,"eighty":-5.129178,"marketCap":18886664},{"date":"2022-04-22","current":-2.458599,"twenty":-13.791467,"median":-11.441349,"eighty":-5.008289,"marketCap":18532539},{"date":"2022-04-29","current":-2.570273,"twenty":-13.719029,"median":-9.291239,"eighty":-4.835589,"marketCap":19374320},{"date":"2022-05-06","current":-2.538928,"twenty":-13.699815,"median":-8.634981,"eighty":-4.058441,"marketCap":19138048},{"date":"2022-05-13","current":-2.04213,"twenty":-13.699815,"median":-8.410471,"eighty":-3.626692,"marketCap":17543210},{"date":"2022-05-20","current":-2.337792,"twenty":-13.699815,"median":-7.978722,"eighty":-3.601769,"marketCap":20083137},{"date":"2022-05-27","current":-2.131516,"twenty":-13.680601,"median":-7.840562,"eighty":-3.47649,"marketCap":18311095},{"date":"2022-06-03","current":-2.062758,"twenty":-13.680601,"median":-7.736943,"eighty":-3.364188,"marketCap":17720415},{"date":"2022-06-10","current":-2.062758,"twenty":-13.680601,"median":-7.633323,"eighty":-3.319892,"marketCap":17720415},{"date":"2022-06-17","current":-1.966496,"twenty":-13.66523,"median":-7.391543,"eighty":-3.2228,"marketCap":16893462},{"date":"2022-06-24","current":-2.585323,"twenty":-13.636024,"median":-7.115224,"eighty":-3.074412,"marketCap":22209586},{"date":"2022-07-01","current":-2.764095,"twenty":-13.611624,"median":-7.020239,"eighty":-3.074412,"marketCap":23745356},{"date":"2022-07-08","current":-3.492936,"twenty":-13.59779,"median":-6.933889,"eighty":-2.95405,"marketCap":30006569},{"date":"2022-07-15","current":-2.819102,"twenty":-13.569158,"median":-6.735285,"eighty":-2.850291,"marketCap":24217900},{"date":"2022-07-22","current":-3.011626,"twenty":-13.523044,"median":-6.165376,"eighty":-2.810856,"marketCap":25871805},{"date":"2022-07-29","current":-2.337792,"twenty":-13.485398,"median":-6.027216,"eighty":-2.810856,"marketCap":20083137},{"date":"2022-08-05","current":-3.025378,"twenty":-13.480809,"median":-5.733627,"eighty":-2.797099,"marketCap":25989942},{"date":"2022-08-12","current":-2.387956,"twenty":-13.476183,"median":-5.630007,"eighty":-2.769596,"marketCap":24217900},{"date":"2022-08-19","current":-2.370483,"twenty":-13.466679,"median":-5.586832,"eighty":-2.67071,"marketCap":24040696},{"date":"2022-08-26","current":-2.189931,"twenty":-13.457712,"median":-5.500483,"eighty":-2.576293,"marketCap":22209586},{"date":"2022-09-02","current":-2.015202,"twenty":-13.450029,"median":-5.457308,"eighty":-2.553375,"marketCap":20437545},{"date":"2022-09-09","current":-2.213228,"twenty":-13.450029,"median":-5.405498,"eighty":-2.50598,"marketCap":22445859},{"date":"2022-09-16","current":-1.654097,"twenty":-13.450029,"median":-5.284608,"eighty":-2.459191,"marketCap":16775326},{"date":"2022-09-23","current":-1.456071,"twenty":-13.446186,"median":-5.215528,"eighty":-2.41348,"marketCap":14767012},{"date":"2022-09-30","current":-1.316288,"twenty":-13.430814,"median":-5.180988,"eighty":-2.376856,"marketCap":13349379},{"date":"2022-10-07","current":-1.549259,"twenty":-13.430814,"median":-5.163718,"eighty":-2.355337,"marketCap":15712101},{"date":"2022-10-14","current":-1.409477,"twenty":-13.422839,"median":-5.129178,"eighty":-2.337792,"marketCap":14294468},{"date":"2022-10-21","current":-1.351234,"twenty":-13.387384,"median":-5.068734,"eighty":-2.311844,"marketCap":13703787},{"date":"2022-10-28","current":-1.468185,"twenty":-13.369329,"median":-5.008289,"eighty":-2.234187,"marketCap":14889874},{"date":"2022-11-04","current":-1.525962,"twenty":-13.353957,"median":-4.844224,"eighty":-2.203909,"marketCap":15475829},{"date":"2022-11-11","current":-1.315665,"twenty":-13.352036,"median":-4.59381,"eighty":-2.192,"marketCap":14294468},{"date":"2022-11-18","current":-1.367639,"twenty":-13.339288,"median":-4.041171,"eighty":-2.131516,"marketCap":14859158},{"date":"2022-11-25","current":-1.402651,"twenty":-13.319039,"median":-3.831973,"eighty":-2.117765,"marketCap":15239556},{"date":"2022-12-02","current":-1.272171,"twenty":-13.315529,"median":-3.626692,"eighty":-2.062758,"marketCap":13821923},{"date":"2022-12-09","current":-1.174312,"twenty":-13.247141,"median":-3.609422,"eighty":-2.035254,"marketCap":12758698},{"date":"2022-12-16","current":-1.217805,"twenty":-13.238671,"median":-3.540342,"eighty":-2.003554,"marketCap":13231243},{"date":"2022-12-23","current":-1.011213,"twenty":-13.211193,"median":-3.513564,"eighty":-1.980247,"marketCap":10986657},{"date":"2022-12-30","current":-0.978593,"twenty":-13.196813,"median":-3.47649,"eighty":-1.936242,"marketCap":10632249},{"date":"2023-01-06","current":-1.06558,"twenty":-13.15008,"median":-3.409822,"eighty":-1.812384,"marketCap":11577337},{"date":"2023-01-13","current":-1.206932,"twenty":-13.121321,"median":-3.367642,"eighty":-1.649437,"marketCap":13113107},{"date":"2023-01-20","current":-1.293918,"twenty":-13.091404,"median":-3.333102,"eighty":-1.549259,"marketCap":14058195},{"date":"2023-01-27","current":-1.339151,"twenty":-13.046528,"median":-3.319892,"eighty":-1.514314,"marketCap":14549642},{"date":"2023-02-03","current":-1.283045,"twenty":-13.040496,"median":-3.272909,"eighty":-1.477318,"marketCap":13940059},{"date":"2023-02-10","current":-1.304791,"twenty":-13.029794,"median":-3.225932,"eighty":-1.456071,"marketCap":14176332},{"date":"2023-02-17","current":-1.304791,"twenty":-13.021778,"median":-3.103135,"eighty":-1.418796,"marketCap":14176332},{"date":"2023-02-24","current":-1.239552,"twenty":-13.013474,"median":-3.052881,"eighty":-1.409477,"marketCap":13467515},{"date":"2023-03-03","current":-1.228678,"twenty":-13.012399,"median":-3.039321,"eighty":-1.391604,"marketCap":13349379},{"date":"2023-03-10","current":-1.304791,"twenty":-13.004256,"median":-3.025378,"eighty":-1.369017,"marketCap":14176332},{"date":"2023-03-17","current":-1.228678,"twenty":-12.988847,"median":-2.990998,"eighty":-1.359158,"marketCap":13349379},{"date":"2023-03-24","current":-1.337411,"twenty":-12.982967,"median":-2.942868,"eighty":-1.3542,"marketCap":14530740},{"date":"2023-03-31","current":-1.130555,"twenty":-12.959961,"median":-2.892468,"eighty":-1.339585,"marketCap":12881741},{"date":"2023-04-06","current":-1.10461,"twenty":-12.959551,"median":-2.846605,"eighty":-1.337411,"marketCap":12586114},{"date":"2023-04-14","current":-1.104506,"twenty":-12.941576,"median":-2.805359,"eighty":-1.326538,"marketCap":12584927},{"date":"2023-04-21","current":-0.896213,"twenty":-12.873599,"median":-2.784723,"eighty":-1.316288,"marketCap":10211600},{"date":"2023-04-28","current":-0.948208,"twenty":-12.854385,"median":-2.764095,"eighty":-1.315665,"marketCap":10804041},{"date":"2023-05-05","current":-0.912051,"twenty":-12.83373,"median":-2.674867,"eighty":-1.304791,"marketCap":10392063},{"date":"2023-05-12","current":-0.893816,"twenty":-12.815956,"median":-2.626578,"eighty":-1.304791,"marketCap":10184293},{"date":"2023-05-19","current":-0.818627,"twenty":-12.797041,"median":-2.562437,"eighty":-1.30464,"marketCap":9379332},{"date":"2023-05-26","current":-0.921132,"twenty":-12.796742,"median":-2.554601,"eighty":-1.293918,"marketCap":10553777},{"date":"2023-06-02","current":-0.847566,"twenty":-12.754435,"median":-2.538928,"eighty":-1.283045,"marketCap":9710899},{"date":"2023-06-09","current":-0.808192,"twenty":-12.716993,"median":-2.505579,"eighty":-1.276542,"marketCap":9259782},{"date":"2023-06-16","current":-0.816942,"twenty":-12.68722,"median":-2.461557,"eighty":-1.271676,"marketCap":9360030},{"date":"2023-06-23","current":-0.711255,"twenty":-12.611051,"median":-2.429221,"eighty":-1.250425,"marketCap":8149135},{"date":"2023-06-30","current":-0.623143,"twenty":-12.553665,"median":-2.420922,"eighty":-1.239552,"marketCap":7139602},{"date":"2023-07-07","current":-0.602738,"twenty":-12.535942,"median":-2.41162,"eighty":-1.229892,"marketCap":6905804},{"date":"2023-07-14","current":-0.52135,"twenty":-12.529791,"median":-2.383501,"eighty":-1.228678,"marketCap":5973318},{"date":"2023-07-21","current":-0.468272,"twenty":-12.356334,"median":-2.376308,"eighty":-1.217699,"marketCap":5365175},{"date":"2023-07-28","current":-0.990802,"twenty":-11.940451,"median":-2.358826,"eighty":-1.197923,"marketCap":11352007},{"date":"2023-08-04","current":-0.710546,"twenty":-11.791929,"median":-2.337792,"eighty":-1.178727,"marketCap":8141009},{"date":"2023-08-11","current":-0.553305,"twenty":-11.239291,"median":-2.336489,"eighty":-1.174312,"marketCap":6482963},{"date":"2023-08-18","current":-0.517927,"twenty":-9.695356,"median":-2.318065,"eighty":-1.167025,"marketCap":6068451},{"date":"2023-08-25","current":-0.487052,"twenty":-9.301601,"median":-2.277295,"eighty":-1.134776,"marketCap":5706695},{"date":"2023-09-01","current":-0.567327,"twenty":-8.918208,"median":-2.227778,"eighty":-1.124657,"marketCap":6647260},{"date":"2023-09-08","current":-0.524874,"twenty":-8.721331,"median":-2.214027,"eighty":-1.115597,"marketCap":6149846},{"date":"2023-09-15","current":-0.454634,"twenty":-8.631527,"median":-2.200927,"eighty":-1.096554,"marketCap":5326852},{"date":"2023-09-22","current":-0.39417,"twenty":-8.503729,"median":-2.200275,"eighty":-1.029219,"marketCap":4618414},{"date":"2023-09-29","current":-1.955413,"twenty":-8.417379,"median":-2.178282,"eighty":-1.020777,"marketCap":22911192},{"date":"2023-10-06","current":-2.966166,"twenty":-8.213594,"median":-2.200275,"eighty":-1.029219,"marketCap":34753983},{"date":"2023-10-13","current":-2.024979,"twenty":-8.061618,"median":-2.200275,"eighty":-1.052445,"marketCap":23726277},{"date":"2023-10-20","current":-1.868114,"twenty":-7.964906,"median":-2.189931,"eighty":-1.07018,"marketCap":21888326},{"date":"2023-10-27","current":-1.639947,"twenty":-7.909642,"median":-2.189931,"eighty":-1.073246,"marketCap":19214942},{"date":"2023-11-03","current":-2.039239,"twenty":-7.840562,"median":-2.131516,"eighty":-1.094086,"marketCap":23893363},{"date":"2023-11-10","current":-1.72551,"twenty":-7.840562,"median":-2.117765,"eighty":-1.098199,"marketCap":20217461},{"date":"2023-11-17","current":-1.207455,"twenty":-7.823292,"median":-2.100401,"eighty":-1.104506,"marketCap":15371954},{"date":"2023-11-24","current":-1.751578,"twenty":-7.754213,"median":-2.062758,"eighty":-1.104589,"marketCap":22299111},{"date":"2023-12-01","current":-1.619275,"twenty":-7.709311,"median":-2.055882,"eighty":-1.10818,"marketCap":20614771},{"date":"2023-12-08","current":-1.499895,"twenty":-7.688587,"median":-2.040684,"eighty":-1.117771,"marketCap":19094967},{"date":"2023-12-15","current":-1.530505,"twenty":-7.602237,"median":-2.035254,"eighty":-1.119946,"marketCap":19484660},{"date":"2023-12-22","current":-1.511799,"twenty":-7.443353,"median":-2.024979,"eighty":-1.121512,"marketCap":19246514},{"date":"2023-12-29","current":-1.717567,"twenty":-7.401905,"median":-2.021502,"eighty":-1.12328,"marketCap":21866119},{"date":"2024-01-05","current":-1.668421,"twenty":-7.391543,"median":-2.01296,"eighty":-1.125346,"marketCap":21240445},{"date":"2024-01-12","current":-1.564517,"twenty":-7.201574,"median":-2.003554,"eighty":-1.130555,"marketCap":19917653},{"date":"2024-01-19","current":-1.538328,"twenty":-7.132494,"median":-1.982197,"eighty":-1.130555,"marketCap":19584248},{"date":"2024-01-26","current":-1.345144,"twenty":-7.115224,"median":-1.982197,"eighty":-1.130766,"marketCap":17124851},{"date":"2024-02-02","current":-1.360449,"twenty":-7.046144,"median":-1.980247,"eighty":-1.134776,"marketCap":17319698},{"date":"2024-02-09","current":-2.346775,"twenty":-7.015058,"median":-1.974428,"eighty":-1.144518,"marketCap":29876479},{"date":"2024-02-16","current":-2.05768,"twenty":-6.983972,"median":-1.980247,"eighty":-1.160092,"marketCap":26196043},{"date":"2024-02-23","current":-2.48282,"twenty":-6.925254,"median":-1.982197,"eighty":-1.165591,"marketCap":31608449},{"date":"2024-03-01","current":-2.992989,"twenty":-6.818181,"median":-1.982197,"eighty":-1.167025,"marketCap":38103336},{"date":"2024-03-08","current":-3.45214,"twenty":-6.749101,"median":-1.993999,"eighty":-1.167025,"marketCap":43948734},{"date":"2024-03-15","current":-2.924966,"twenty":-6.714561,"median":-2.007136,"eighty":-1.171397,"marketCap":37237351},{"date":"2024-03-22","current":-2.924966,"twenty":-6.431334,"median":-2.021502,"eighty":-1.174312,"marketCap":37237351},{"date":"2024-03-28","current":-2.499826,"twenty":-6.182646,"median":-2.024979,"eighty":-1.174312,"marketCap":31824945},{"date":"2024-04-05","current":-2.652457,"twenty":-6.058302,"median":-2.035254,"eighty":-1.174312,"marketCap":37789883},{"date":"2024-04-12","current":-2.171602,"twenty":-6.027216,"median":-2.039239,"eighty":-1.174312,"marketCap":30939085},{"date":"2024-04-19","current":-2.031999,"twenty":-6.0134,"median":-2.036876,"eighty":-1.174442,"marketCap":28950144},{"date":"2024-04-26","current":-2.063022,"twenty":-5.90978,"median":-2.039239,"eighty":-1.176682,"marketCap":29392131},{"date":"2024-05-03","current":-1.915663,"twenty":-5.743989,"median":-2.036876,"eighty":-1.181923,"marketCap":27292693},{"date":"2024-05-10","current":-1.969953,"twenty":-5.681817,"median":-2.038499,"eighty":-1.189535,"marketCap":28066170},{"date":"2024-05-17","current":-1.913251,"twenty":-5.661093,"median":-2.035254,"eighty":-1.196059,"marketCap":28508157},{"date":"2024-05-24","current":-1.839094,"twenty":-5.616191,"median":-2.031999,"eighty":-1.196991,"marketCap":27403190},{"date":"2024-05-31","current":-1.759717,"twenty":-5.595467,"median":-2.024979,"eighty":-1.200098,"marketCap":26220447},{"date":"2024-06-07","current":-1.56585,"twenty":-5.592013,"median":-2.018995,"eighty":-1.206932,"marketCap":23331753},{"date":"2024-06-14","current":-1.551086,"twenty":-5.578197,"median":-2.016488,"eighty":-1.206932,"marketCap":23111768},{"date":"2024-06-21","current":-1.893933,"twenty":-5.550566,"median":-2.01296,"eighty":-1.20735,"marketCap":28220311},{"date":"2024-06-28","current":-1.714978,"twenty":-5.535023,"median":-2.007136,"eighty":-1.209419,"marketCap":25553825},{"date":"2024-07-05","current":-1.640414,"twenty":-5.500483,"median":-2.002265,"eighty":-1.217275,"marketCap":24442789},{"date":"2024-07-12","current":-1.67024,"twenty":-5.491848,"median":-1.989657,"eighty":-1.217805,"marketCap":24887204},{"date":"2024-07-15","current":-1.700066,"twenty":-5.48494,"median":-1.985927,"eighty":-1.218849,"marketCap":25331618},{"date":"2024-08-02","current":-1.685153,"twenty":-5.478032,"median":-1.982197,"eighty":-1.219893,"marketCap":25109411},{"date":"2024-08-09","current":-1.14502,"twenty":-5.457308,"median":-1.982197,"eighty":-1.219893,"marketCap":19112039},{"date":"2024-08-16","current":-1.465187,"twenty":-5.436584,"median":-1.980247,"eighty":-1.225286,"marketCap":24456078},{"date":"2024-08-23","current":-1.345308,"twenty":-5.405498,"median":-1.969953,"eighty":-1.228678,"marketCap":22455126},{"date":"2024-08-30","current":-1.545106,"twenty":-5.36405,"median":-1.969953,"eighty":-1.228678,"marketCap":25790046},{"date":"2024-09-06","current":-1.465187,"twenty":-5.298424,"median":-1.966496,"eighty":-1.228678,"marketCap":24456078},{"date":"2024-09-13","current":-1.491826,"twenty":-5.274246,"median":-1.947202,"eighty":-1.228678,"marketCap":24900734},{"date":"2024-09-20","current":-1.558426,"twenty":-5.232798,"median":-1.925241,"eighty":-1.229892,"marketCap":26012374},{"date":"2024-09-27","current":-1.505146,"twenty":-5.22589,"median":-1.908603,"eighty":-1.23544,"marketCap":25123062},{"date":"2024-10-04","current":-1.485166,"twenty":-5.194804,"median":-1.898419,"eighty":-1.238478,"marketCap":24789570},{"date":"2024-10-11","current":-1.491826,"twenty":-5.180988,"median":-1.885328,"eighty":-1.239552,"marketCap":24900734},{"date":"2024-10-18","current":-1.625025,"twenty":-5.177534,"median":-1.870618,"eighty":-1.239552,"marketCap":27124014},{"date":"2024-10-25","current":-1.598385,"twenty":-5.163718,"median":-1.860984,"eighty":-1.239552,"marketCap":26679358},{"date":"2024-10-31","current":-1.811503,"twenty":-5.163718,"median":-1.846723,"eighty":-1.239552,"marketCap":30236606},{"date":"2024-11-08","current":-1.505146,"twenty":-5.163718,"median":-1.838143,"eighty":-1.250425,"marketCap":25123062},{"date":"2024-11-15","current":-1.203539,"twenty":-5.146448,"median":-1.803051,"eighty":-1.250425,"marketCap":21788143},{"date":"2024-11-22","current":-1.240382,"twenty":-5.129178,"median":-1.787723,"eighty":-1.239552,"marketCap":22455126},{"date":"2024-11-29","current":-1.416656,"twenty":-5.129178,"median":-1.771544,"eighty":-1.239552,"marketCap":25646284},{"date":"2024-12-06","current":-1.391358,"twenty":-5.08773,"median":-1.759717,"eighty":-1.239552,"marketCap":25188314},{"date":"2024-12-13","current":-1.505197,"twenty":-5.063553,"median":-1.751578,"eighty":-1.240216,"marketCap":27249176},{"date":"2024-12-20","current":-1.391358,"twenty":-5.018651,"median":-1.742287,"eighty":-1.248416,"marketCap":25188314},{"date":"2024-12-27","current":-1.454602,"twenty":-5.008289,"median":-1.735455,"eighty":-1.250425,"marketCap":26333238},{"date":"2025-01-03","current":-1.391358,"twenty":-5.006699,"median":-1.728547,"eighty":-1.256233,"marketCap":25188314},{"date":"2025-01-10","current":-1.37871,"twenty":-4.991293,"median":-1.721594,"eighty":-1.265894,"marketCap":24959330},{"date":"2025-01-17","current":-1.404007,"twenty":-4.921939,"median":-1.717567,"eighty":-1.269694,"marketCap":25417299},{"date":"2025-01-24","current":-1.454602,"twenty":-4.852859,"median":-1.714978,"eighty":-1.269694,"marketCap":26333238},{"date":"2025-01-31","current":-1.505197,"twenty":-4.835589,"median":-1.705658,"eighty":-1.272171,"marketCap":27249176},{"date":"2025-02-07","current":-1.492548,"twenty":-4.818319,"median":-1.700066,"eighty":-1.272171,"marketCap":27020192},{"date":"2025-02-14","current":-1.745522,"twenty":-4.59381,"median":-1.694563,"eighty":-1.272171,"marketCap":31599885},{"date":"2025-02-21","current":-2.238822,"twenty":-4.276042,"median":-1.700066,"eighty":-1.272258,"marketCap":40530288},{"date":"2025-02-28","current":-2.011145,"twenty":-4.086073,"median":-1.71125,"eighty":-1.272616,"marketCap":36408564},{"date":"2025-03-07","current":-1.897307,"twenty":-4.030809,"median":-1.716273,"eighty":-1.276626,"marketCap":34347702},{"date":"2025-03-14","current":-1.77082,"twenty":-3.899557,"median":-1.717567,"eighty":-1.281958,"marketCap":32057855},{"date":"2025-03-21","current":-2.023794,"twenty":-3.840605,"median":-1.725217,"eighty":-1.283045,"marketCap":36637548},{"date":"2025-03-28","current":-1.624598,"twenty":-3.803107,"median":-1.731584,"eighty":-1.283045,"marketCap":30569454},{"date":"2025-04-04","current":-1.774732,"twenty":-3.779292,"median":-1.733429,"eighty":-1.283045,"marketCap":33394464},{"date":"2025-04-11","current":-1.558301,"twenty":-3.674049,"median":-1.724924,"eighty":-1.283045,"marketCap":29321968},{"date":"2025-04-17","current":-1.558301,"twenty":-3.635515,"median":-1.717567,"eighty":-1.287756,"marketCap":29321968},{"date":"2025-04-25","current":-1.78916,"twenty":-3.623994,"median":-1.725217,"eighty":-1.292709,"marketCap":33665964},{"date":"2025-05-02","current":-1.688159,"twenty":-3.619336,"median":-1.718264,"eighty":-1.293918,"marketCap":31765466},{"date":"2025-05-09","current":-1.659302,"twenty":-3.612625,"median":-1.717567,"eighty":-1.293918,"marketCap":31222466},{"date":"2025-05-16","current":-1.375889,"twenty":-3.609422,"median":-1.714978,"eighty":-1.293918,"marketCap":29050468},{"date":"2025-05-23","current":-1.367545,"twenty":-3.60483,"median":-1.706919,"eighty":-1.293918,"marketCap":28874278},{"date":"2025-05-30","current":-1.315939,"twenty":-3.581399,"median":-1.701327,"eighty":-1.297566,"marketCap":27784682},{"date":"2025-06-06","current":-1.226645,"twenty":-3.546643,"median":-1.700066,"eighty":-1.293918,"marketCap":25899328},{"date":"2025-06-13","current":-1.424967,"twenty":-3.539857,"median":-1.689892,"eighty":-1.286185,"marketCap":30086698},{"date":"2025-06-20","current":-1.355645,"twenty":-3.538142,"median":-1.686793,"eighty":-1.2915,"marketCap":28623020},{"date":"2025-06-27","current":-1.514625,"twenty":-3.52594,"median":-1.678305,"eighty":-1.293918,"marketCap":31979720},{"date":"2025-07-03","current":-1.434672,"twenty":-3.492936,"median":-1.673731,"eighty":-1.293918,"marketCap":30291612},{"date":"2025-07-11","current":-1.461477,"twenty":-3.47649,"median":-1.671985,"eighty":-1.293918,"marketCap":30857567},{"date":"2025-07-18","current":-1.443145,"twenty":-3.47649,"median":-1.668421,"eighty":-1.293918,"marketCap":30470506},{"date":"2025-07-25","current":-1.40987,"twenty":-3.469146,"median":-1.659302,"eighty":-1.293918,"marketCap":29767941},{"date":"2025-08-01","current":-1.277387,"twenty":-3.45214,"median":-1.655327,"eighty":-1.293918,"marketCap":26970691},{"date":"2025-08-08","current":-1.359342,"twenty":-3.436722,"median":-1.650816,"eighty":-1.293918,"marketCap":28701083},{"date":"2025-08-15","current":-1.150779,"twenty":-3.401123,"median":-1.644873,"eighty":-1.290896,"marketCap":24183982},{"date":"2025-08-22","current":-0.87967,"twenty":-3.382923,"median":-1.64366,"eighty":-1.283045,"marketCap":18486543},{"date":"2025-08-29","current":-0.730023,"twenty":-3.367642,"median":-1.640414,"eighty":-1.277387,"marketCap":15341664},{"date":"2025-09-05","current":-0.753559,"twenty":-3.367642,"median":-1.640414,"eighty":-1.272171,"marketCap":15836279},{"date":"2025-09-12","current":-0.751103,"twenty":-3.353826,"median":-1.639146,"eighty":-1.268744,"marketCap":15784667},{"date":"2025-09-19","current":-0.736368,"twenty":-3.336556,"median":-1.625501,"eighty":-1.249378,"marketCap":15474995},{"date":"2025-09-26","current":-0.706078,"twenty":-3.333102,"median":-1.624811,"eighty":-1.239552,"marketCap":14838447},{"date":"2025-10-03","current":-0.849136,"twenty":-3.322534,"median":-1.616016,"eighty":-1.233534,"marketCap":17844846},{"date":"2025-10-10","current":-1.32845,"twenty":-3.319892,"median":-1.611518,"eighty":-1.233534,"marketCap":27917786},{"date":"2025-10-17","current":-1.525538,"twenty":-3.31531,"median":-1.601198,"eighty":-1.228678,"marketCap":32059648},{"date":"2025-10-24","current":-1.245767,"twenty":-3.302105,"median":-1.598385,"eighty":-1.228678,"marketCap":26180182},{"date":"2025-10-31","current":-1.271759,"twenty":-3.278145,"median":-1.581522,"eighty":-1.228678,"marketCap":26726409},{"date":"2025-11-07","current":-1.598806,"twenty":-3.267089,"median":-1.581522,"eighty":-1.230234,"marketCap":33599406},{"date":"2025-11-14","current":-1.691722,"twenty":-3.264345,"median":-1.598385,"eighty":-1.233923,"marketCap":35552060},{"date":"2025-11-21","current":-2.358818,"twenty":-3.251263,"median":-1.598456,"eighty":-1.237517,"marketCap":46707589},{"date":"2025-11-28","current":-2.976892,"twenty":-3.234788,"median":-1.600002,"eighty":-1.239015,"marketCap":58946227},{"date":"2025-12-05","current":-2.653265,"twenty":-3.225932,"median":-1.607502,"eighty":-1.239552,"marketCap":52538013},{"date":"2025-12-12","current":-2.520337,"twenty":-3.21881,"median":-1.617646,"eighty":-1.239552,"marketCap":49905860},{"date":"2025-12-19","current":-2.350566,"twenty":-3.211789,"median":-1.625025,"eighty":-1.239552,"marketCap":46544174}],"updateTime":1766476925679},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FEMY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592045879","title":"Femasys Secures FDA Clearance for Next-Generation FemVue Controlled Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2592045879","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592045879?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:15","pubTimestamp":1766067310,"startTime":"0","endTime":"0","summary":"Femasys Inc. has received 510 clearance from the United States Food and Drug Administration  for its FemVue Controlled device, a next-generation diagnostic solution designed for controlled contrast delivery to evaluate fallopian tube status. The FemVue Controlled device integrates features from the company's original FemVue and FemChec technologies into a single FDA-cleared product, supporting multiple clinical uses and improving workflow efficiency for clinicians.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire  on December 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL3rvRxc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","BK4585","BK4112","LU0314104364.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","SG9999014005.SGD","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","BK4539","IE00BKPKM429.USD","BK4082","FEMY","SG9999014021.USD","BK4584"],"gpt_icon":0},{"id":"2592393904","title":"Femasys Secures U.S. FDA Clearance for Next-Generation Femvue Diagnostic Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2592393904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592393904?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:15","pubTimestamp":1766067300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nTUA9TFKGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4539","BK4082","FEMY"],"gpt_icon":0},{"id":"2586471515","title":"PharmaCyte sells Femasys stake, sees cash position rising to $20M","url":"https://stock-news.laohu8.com/highlight/detail?id=2586471515","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586471515?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:25","pubTimestamp":1764080720,"startTime":"0","endTime":"0","summary":"PharmaCyte Biotech (PMCB) announced the successful monetization of its stake in Femasys (FEMY). Following the monetization of the stake, PharmaCyte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharmacyte-sells-femasys-stake-sees-cash-position-rising-to-20m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharmacyte-sells-femasys-stake-sees-cash-position-rising-to-20m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4139","PMCB","BK4082","BK4539","FEMY"],"gpt_icon":0},{"id":"2584158996","title":"Femasys Initiated at Buy by Laidlaw & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584158996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584158996?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:51","pubTimestamp":1763650260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FEMY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 20, 2025 09:51 ET (14:51 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","FEMY","BK4082","BK4539"],"gpt_icon":0},{"id":"2584699180","title":"Femasys initiated with a Buy at Laidlaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2584699180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584699180?lang=en_us&edition=fundamental","pubTime":"2025-11-20 18:00","pubTimestamp":1763632827,"startTime":"0","endTime":"0","summary":"Laidlaw analyst Yale Jen initiated coverage of Femasys (FEMY) with a Buy rating and $6.50 price target Femasys is a development stage medical techn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-initiated-with-a-buy-at-laidlaw-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-initiated-with-a-buy-at-laidlaw-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4584","FEMY","BK4539"],"gpt_icon":0},{"id":"2584923411","title":"Femasys: Strategic Advancements and Financial Health Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2584923411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584923411?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:05","pubTimestamp":1763568329,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Femasys, with a price target of $3.00. Jason McCarthy ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/femasys-strategic-advancements-and-financial-health-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/femasys-strategic-advancements-and-financial-health-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FEMY"],"gpt_icon":0},{"id":"2583684851","title":"Femasys Q3 sales rise, driven by FemBloc sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2583684851","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583684851?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:10","pubTimestamp":1763154606,"startTime":"0","endTime":"0","summary":"Femasys Q3 sales rise, driven by FemBloc salesOverviewFemasys Q3 sales increased 31.4% yr/yr, driven by FemBloc salesCompany reduced Q3 net loss compared to prior yearFemasys secured $12 mln financing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL1N3WQ13I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","FEMY","BK4584"],"gpt_icon":0},{"id":"2583681089","title":"Femasys Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $729.394K Miss $1.450M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583681089","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583681089?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:05","pubTimestamp":1763154311,"startTime":"0","endTime":"0","summary":"Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 13.04 percent. This is a 58.33 percent increase over losses of $(0.24) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48879715/femasys-q3-eps-0-10-beats-0-12-estimate-sales-729-394k-miss-1-450m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Femasys Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $729.394K Miss $1.450M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY"],"gpt_icon":0},{"id":"2583429681","title":"Femasys Inc. reports nine-month sales of $1.48 million and net loss of $14.68 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583429681","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583429681?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:01","pubTimestamp":1763154085,"startTime":"0","endTime":"0","summary":"Femasys Inc. reported sales of $1.5 million for the nine months ended September 30, 2025, an increase of 41.3% from $1.0 million in the same period of 2024, driven by sales of FemBloc and FemVue. Research and development expenses decreased 4.7% to $5.8 million from $6.0 million. Net loss for the period was $14.7 million, or  per share, compared to a net loss of $13.7 million, or  per share, for the prior year period. Cash and cash equivalents totaled $4.6 million at the end of September 2025, up from $3.5 million at the end of 2024. Business developments included a second partner order for FemBloc in Europe, FDA approval to continue the final phase of the FemBloc FINALE trial, and a $12 million financing agreement with potential total funding of $58 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL6SQyN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","FEMY","IE00B64PRP62.GBP","BK4082","LU0314104364.USD","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","BK4585","LU2210150020.SGD","BK4584","IE00BGHQF748.EUR","BK4539","NDAQ","BK4588"],"gpt_icon":0},{"id":"2583681410","title":"Femasys Inc. Q3 EPS USD -0.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2583681410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583681410?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:01","pubTimestamp":1763154061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nPLX5BE18C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4539","BK4082","FEMY"],"gpt_icon":0},{"id":"2583681447","title":"Press Release: Femasys Announces Third Quarter Financial Results for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583681447","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583681447?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:01","pubTimestamp":1763154060,"startTime":"0","endTime":"0","summary":"-- FDA Approval to Advance Final FemBloc Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval --. -- $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway --. ATLANTA, Nov. 14, 2025  -- Femasys Inc. , a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the third quarter of 2025.-- Announced second partner order for FemBloc in Europe. -- Announced FDA IDE approval to continue enrollment in final phase of the. -- Announced a definitive agreement for the issuance of $12 million in. secured convertible notes and accompanying warrants for total potential. funding of $58 million, if all warrants are exercised for cash. -- Announced the initiation of post-market surveillance study for FemBloc in. -- Announced partnership with Kebomed, a leading European distributor of. medical devices and equipment, to commercialize FemBloc in France an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4099","BK4604","R","03160","TM","BK4539","BK4584","BK4588","BK4232","BK4022","BK4555","FEMY","BK4585"],"gpt_icon":0},{"id":"2582872770","title":"Femasys advances global growth with second partner order for FemBloc in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872770?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:16","pubTimestamp":1762784199,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced a significant initial order valued at approximately $500,000 USD for the commercial launch of FemBloc Permanent Birth Cont...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-advances-global-growth-with-second-partner-order-for-fembloc-in-europe-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-advances-global-growth-with-second-partner-order-for-fembloc-in-europe-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FEMY","BK4539","BK4082","BK4584"],"gpt_icon":0},{"id":"2582728328","title":"Femasys Secures $500,000 Order for FemBloc Launch in France and Benelux","url":"https://stock-news.laohu8.com/highlight/detail?id=2582728328","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582728328?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:00","pubTimestamp":1762783222,"startTime":"0","endTime":"0","summary":"Femasys Inc. has announced an initial order valued at approximately $500,000 USD for the commercial launch of its FemBloc Permanent Birth Control product in France and the Benelux region. This order is part of a partnership with distributor Kebomed and follows the company's recent entry into the Spanish market. FemBloc is a non-surgical permanent contraceptive solution that uses a proprietary polymer to achieve permanent occlusion of the fallopian tubes. The company states that this order reflects continued progress in expanding FemBloc's presence in key European markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire  on November 10, 2025, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL16m3wV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2210149790.SGD","LU0314104364.USD","NDAQ","FEMY","BK4588","BK4584","BK4112","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","LU2095319765.USD","BK4539"],"gpt_icon":0},{"id":"2582872274","title":"Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872274","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872274?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:00","pubTimestamp":1762783200,"startTime":"0","endTime":"0","summary":"-- Continued rollout of FemBloc, the breakthrough non-surgical permanent contraceptive solution, expands the Company’s presence in key European Markets -- ATLANTA, Nov.  10, 2025  (GLOBE NEWSWIRE) -- ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184661/0/en/Femasys-Advances-Global-Growth-with-Second-Partner-Order-for-FemBloc-in-Europe.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4539","BK4082","BK4584"],"gpt_icon":0},{"id":"2581683733","title":"Femasys Secures $12 Million Through Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2581683733","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581683733?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:30","pubTimestamp":1762554633,"startTime":"0","endTime":"0","summary":"Femasys ( ($FEMY) ) just unveiled an announcement. Femasys Inc. announced on November 3, 2025, that it has entered into a Securities Purchase Agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/femasys-secures-12-million-through-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/femasys-secures-12-million-through-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","FEMY","BK4584","BK4539"],"gpt_icon":0},{"id":"2581091834","title":"Femasys Inc. Announces Private Placement of Convertible Notes and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2581091834","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581091834?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:09","pubTimestamp":1762553358,"startTime":"0","endTime":"0","summary":"Femasys Inc. has announced a private placement with certain accredited investors, agreeing to sell senior secured convertible notes that are convertible into shares of the company's common stock at a conversion price of $0.73 per share. As part of the transaction, investors will also receive Series A-1, B-1, and C-1 warrants to purchase common stock at exercise prices of $0.81, $0.92, and $1.10 per share, respectively. The private placement is exempt from registration under the Securities Act and will be used to repay senior convertible notes issued in November 2023 and for general corporate purposes. Company insiders, including the CEO, CFO, and a board member, participated on the same terms as other investors, purchasing an aggregate of approximately $100,000 in notes and warrants. Femasys has also agreed to file a registration statement to register the resale of the conversion and warrant shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL2gCjVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4539","FEMY","BK4082"],"gpt_icon":0},{"id":"2580152612","title":"Femasys Secures FDA IDE Approval to Advance Final FemBloc Trial Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2580152612","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580152612?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176631,"startTime":"0","endTime":"0","summary":"Femasys Inc. announced that it has received U.S. Food and Drug Administration  Investigational Device Exemption  approval to continue enrollment in the final phase  of the pivotal FINALE trial for FemBloc, its non-surgical permanent birth control device. This regulatory milestone follows successful completion of the first part of the trial and is a key step toward potential U.S. Pre-Market Approval  for FemBloc. The announcement is specific to Femasys Inc.; no other organizations were mentioned as recipients of the grant or regulatory approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire  on November 03, 2025, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL1jBFlN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","BK4112","FEMY","BK4588","BK4584","BK4539","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4082","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2580780215","title":"Femasys Inc: Agreement to Issue $12 Mln Principal Amount of Senior Secured Convertible Notes, Warrants to Purchase Shares of Common Stock for $58 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2580780215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580780215?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUABJWGHS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4082","BK4584","FEMY"],"gpt_icon":0},{"id":"2580215463","title":"Femasys Secures FDA Approval to Advance Final Fembloc® Trial Phase and $12 Million Financing, With Potential to Reach $58 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215463?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUABJWGHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4539","BK4584","FEMY"],"gpt_icon":0},{"id":"2580157342","title":"Femasys: to Use $12 Mln Notes Proceeds to Refinance Existing Debt, Advance Commercialization of Co's' Fertility and Permanent Birth Control Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2580157342","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580157342?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUABJWGHS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4539","BK4082","FEMY"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}